Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00303927
Status:
COMPLETED
Last Update Posted:
2010-03-19
First Post:
2006-03-15
Brief Title:
Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization Data
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Class:
OTHER
Study ID:
CDR0000462118
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Wells Messersmith
Old Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |